Comparison of VRS-317, a Long-acting Human Growth Hormone, to daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children with Growth Hormone Deficiency
|Effective start/end date||3/16/15 → 12/31/17|
- VERSARTIS, INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.